06-007: Securing a Competitive Advantage in the Reverse Transcriptase Market

06-007: Securing a Competitive Advantage in the Reverse Transcriptase Market

This report provides insight into customer behavior, brand warfare, pricing strategy, and market growth potential in the reverse transcriptase market.

Securing a Competitive Advantage in the Reverse Transcriptase Market provides insight into customer behavior, brand warfare, pricing strategy, and market growth potential in this complex and important market.

From a product strategy perspective, reverse transcriptase is critical because it serves as an entry point into a supplier’s profitable kits and reagents (as well as instrumentation) for the RT-PCR and real-time PCR markets. Dominance in such an important market foothold can secure a key competitive advantage for a supplier. However worthwhile, attaining and maintaining such a position in the reverse transcriptase market is difficult due to the presence of several key players. An effective competitive strategy requires a thorough and nuanced understanding of market dynamics that this study is designed to provide.

Based upon a 24-question survey of over 500 life scientist customers in the North American market for reverse transcriptase, BioInformatics LLC uses sophisticated statistical analysis, including Brand Asset Valuator (BAV) Methodology and Van Westendorp Price Sensitivity Analysis, to provide a thorough and nuanced analysis of market dynamics. Results highlight a set of strategic leverage points to assist any competitor in maintaining dominance or gaining share in the reverse transcriptase market.

Included in the report are

-- Comparative assessment of each leading brand’s performance, both past and future
-- Breakdown of key elements that contribute to brand performance
-- Examination of the relationship between price and performance
-- Critical factors placing suppliers at risk for losing customers to competitors
-- Comprehensive assessment of market expectations

This report provides insight into customer behavior, brand warfare, pricing strategy, and market growth potential in the reverse transcriptase market.

Securing a Competitive Advantage in the Reverse Transcriptase Market provides insight into customer behavior, brand warfare, pricing strategy, and market growth potential in this complex and important market.

From a product strategy perspective, reverse transcriptase is critical because it serves as an entry point into a supplier’s profitable kits and reagents (as well as instrumentation) for the RT-PCR and real-time PCR markets. Dominance in such an important market foothold can secure a key competitive advantage for a supplier. However worthwhile, attaining and maintaining such a position in the reverse transcriptase market is difficult due to the presence of several key players. An effective competitive strategy requires a thorough and nuanced understanding of market dynamics that this study is designed to provide.

Based upon a 24-question survey of over 500 life scientist customers in the North American market for reverse transcriptase, BioInformatics LLC uses sophisticated statistical analysis, including Brand Asset Valuator (BAV) Methodology and Van Westendorp Price Sensitivity Analysis, to provide a thorough and nuanced analysis of market dynamics. Results highlight a set of strategic leverage points to assist any competitor in maintaining dominance or gaining share in the reverse transcriptase market.

Included in the report are

-- Comparative assessment of each leading brand’s performance, both past and future
-- Breakdown of key elements that contribute to brand performance
-- Examination of the relationship between price and performance
-- Critical factors placing suppliers at risk for losing customers to competitors
-- Comprehensive assessment of market expectations